CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,417,832 | -6.5% | 217,849 | +3.6% | 0.01% | 0.0% |
| Q2 2023 | $6,860,965 | -2.4% | 210,330 | +5.3% | 0.01% | -9.1% |
| Q1 2023 | $7,026,317 | -23.2% | 199,668 | -0.1% | 0.01% | -31.2% |
| Q4 2022 | $9,154,698 | -5.1% | 199,797 | +0.3% | 0.02% | -11.1% |
| Q3 2022 | $9,647,000 | +22.7% | 199,103 | -0.5% | 0.02% | +28.6% |
| Q2 2022 | $7,862,000 | +7.3% | 200,094 | +0.5% | 0.01% | +27.3% |
| Q1 2022 | $7,329,000 | -17.5% | 199,080 | +2.1% | 0.01% | -15.4% |
| Q4 2021 | $8,889,000 | +88.9% | 195,011 | +48.1% | 0.01% | +85.7% |
| Q3 2021 | $4,705,000 | – | 131,654 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |